Group 1 - The core viewpoint of the articles highlights the growth in China's metal forming machine tool production, with a projected output of 17,000 units in December 2025, reflecting a year-on-year increase of 6.3% [1] - Cumulative production for the entire year of 2025 is expected to reach 179,000 units, marking a total growth of 7.2% [1] - The report by Zhiyan Consulting provides insights into the investment prospects and market research for the smart machine tool industry in China from 2026 to 2032 [1] Group 2 - The data source for the production statistics is the National Bureau of Statistics, with additional analysis provided by Zhiyan Consulting [2] - Zhiyan Consulting is recognized as a leading industry consulting firm in China, specializing in in-depth industry research and providing comprehensive consulting services for investment decisions [2]

Core Viewpoint - The industrial robot industry in China is experiencing significant growth, with a projected production increase and a strong market outlook for the coming years [1] Group 1: Industry Overview - According to the National Bureau of Statistics, the production of industrial robots in China is expected to reach 90,000 units by December 2025, representing a year-on-year growth of 14.7% [1] - The cumulative production of industrial robots in China from January to December 2025 is projected to be 773,000 units, reflecting a cumulative growth of 28% [1] Group 2: Companies Involved - Key listed companies in the industrial robot sector include: Robot (300024), Estun (002747), New Times (002527), Tosida (300607), Huichuan Technology (300124), Huazhong CNC (300161), Jasic Technology (300193), Yawen Co. (002559), TuoShan Heavy Industry (001226), and Haozhi Electromechanical (300503) [1] Group 3: Research and Reports - Zhiyan Consulting has released a report titled "Research on Competitive Strategies and Future Prospects of China's Industrial Robot Industry from 2026 to 2032," indicating a focus on strategic insights and market forecasts for the industry [1]

Core Viewpoint - The acquisition of control over Awei Co., Ltd. (002559.SZ) by the state-owned assets of Yangzhou is progressing, with a revised private placement plan that reduces the number of shares and fundraising amount, moving closer to completion of the transaction [1][3]. Group 1: Acquisition Details - Awei Co., Ltd. has adjusted its private placement plan, reducing the number of shares from 99.72 million to 92.09 million and the fundraising amount from 719 million to 664 million yuan [1][5]. - Upon completion, Yangzhou Industrial Investment Development Group will hold 14.35% of Awei's shares, becoming the actual controller of the company [1][3]. - The control transfer marks the re-entry of Yangzhou state-owned assets into the A-share market after nearly 20 years, with Awei becoming the second listed company controlled by Yangzhou state assets after Lianhuan Pharmaceutical [1][13]. Group 2: Historical Context - Awei Co., Ltd. was listed in March 2011, originally controlled by founders Leng Zhibin and Ji Suqin, who held 26.1% of the shares at the time of listing [3][5]. - The company has faced challenges in capital operations, previously attempting to introduce strategic investors and transfer control, all of which failed [5][12]. - The initial plan for the private placement aimed to raise approximately 934 million yuan, which has since been significantly reduced [5][12]. Group 3: Financial Performance - Awei's revenue has increased due to multiple acquisitions, but its profitability has stagnated, with annual profits fluctuating around 100 million yuan [12]. - The company's gross profit margin has declined from nearly 30% in 2019 to approximately 22% in the first three quarters of 2025, indicating a mismatch between revenue growth and profitability [12]. - The debt level has risen significantly, with the asset-liability ratio increasing from about 30% in 2018 to around 63% by the end of the third quarter of 2025 [12]. Group 4: Strategic Importance - Yangzhou Industrial Investment Development Group, as a state-owned platform, is expected to conduct thorough evaluations before making investments, indicating a strategic approach to the acquisition [8][9]. - Awei Co., Ltd. is recognized as a key player in the metal forming machine tool industry, with its products widely used across various sectors, including automotive and aerospace [9][12]. - If the acquisition is successful, it will break the long-standing situation where Lianhuan Pharmaceutical was the only listed company controlled by Yangzhou state assets [13][15].

Core Viewpoint - The company, Ayway Co., Ltd. (002559.SZ), has adjusted its plan for a specific issuance of A-shares for the year 2025, focusing on the total amount of funds raised and the number of shares to be issued [1] Group 1: Fundraising Adjustments - The total amount of funds to be raised has been reduced from 719.03 million yuan to 664.03 million yuan, a decrease of approximately 7.65% [1] - The number of shares to be issued has been adjusted from 99,726,887 shares to 92,098,593 shares [1] Group 2: Fund Allocation - The amount allocated for the servo press and automated stamping line production phase II project remains unchanged at 233.42 million yuan, with a total investment of 303.66 million yuan [1] - Adjustments were primarily made to the allocation for working capital and repayment of bank loans, with the amount reduced from 485.61 million yuan to 430.61 million yuan, and the total investment for this project adjusted to 430.61 million yuan [1] - The combined total investment for both projects has decreased from 789.27 million yuan to 734.27 million yuan [1]

Meeting Overview - The sixth board meeting of Jiangsu Yawen Machine Tool Co., Ltd. was held on January 28, 2026, with all nine directors present, including three participating via telecommunication [2][3]. Resolutions Passed - The board unanimously approved the adjustment of the fundraising amount for the 2025 A-share issuance to specific targets, reducing the total from 71,903.09 million yuan to 66,403.09 million yuan [3][6]. - The number of shares to be issued was adjusted from 99,726,887 shares to 92,098,593 shares, maintaining the limit of 30% of the total share capital before the issuance [4][37]. Fundraising Purpose - The funds raised will be used for the second phase of the servo press and automated stamping line project, as well as to supplement working capital and repay bank loans, which will help optimize the company's capital structure and reduce financial leverage [24][51]. Feasibility Analysis - The board approved the revised feasibility analysis report for the 2025 A-share issuance, which was published on January 29, 2026 [7][14]. Risk Mitigation Measures - The company has committed to measures to mitigate the dilution of immediate returns from the issuance, including improving corporate governance and ensuring effective use of raised funds [25][29]. Shareholder Commitment - The controlling shareholder, Yangzhou Industrial Investment Development Group, has made commitments to not interfere with the company's management and to ensure the fulfillment of return compensation measures [30][31]. Financial Impact - The issuance is expected to enhance the company's capital strength and reduce the debt-to-asset ratio, which has been increasing over the past few years, thereby improving financial stability [49][52].

Core Viewpoint - The company plans to raise a total of 664.03 million yuan through a private placement of shares, which will be allocated for specific investment projects and financial needs [1] Fundraising Purpose - The raised funds will be used for the investment in the second phase of the servo press machine and automated stamping line production project, supplementing working capital, and repaying bank loans [1] Fund Allocation Flexibility - The company has the flexibility to adjust the order and specific amounts of the investment projects based on the progress and actual funding needs [1] Pre-funding Investment - Before the raised funds are in place, the company may use its own funds for the investment projects and will replace these with the raised funds once they are available [1]

Group 1 - The company plans to raise a total of 664.03 million yuan through a private placement of shares [1] - The raised funds will be used for the investment in the second phase of the servo press and automated stamping line project, supplementing working capital, and repaying bank loans [1] - The company may adjust the order and specific amounts of the investment projects based on actual project progress and funding needs [1] Group 2 - Before the raised funds are in place, the company can use its own funds for the investment projects and replace them with the raised funds once they are available [1]

2025 年度向特定对象发行 A 股股票预案 （修订稿） $$\Xi{\cal O}\,{\underline{{{\rightarrow}}}}\,\rlap{{\wedge}}\,\rlap{{\leftarrow}}\,\rlap{{\rightarrow}}\,\rlap{{\rightarrow}}\,\rlap{{\rightarrow}}\,$$ 江苏亚威机床股份有限公司 向特定对象发行股票预案 证券代码：002559 证券简称：亚威股份 江苏亚威机床股份有限公司 （江苏省扬州市江都区黄海南路仙城工业园） 公司声明 本公司及董事会全体成员保证本预案内容真实、准确、完整，并确认不存在 虚假记载、误导性陈述或重大遗漏。 本次向特定对象发行股票完成后，公司经营与收益的变化由公司自行负责， 因本次向特定对象发行股票引致的投资风险由投资者自行负责。 本预案是公司董事会对本次向特定对象发行股票的说明，任何与之相反的声 明均属不实陈述。 投资者如有任何疑问，应咨询自己的股票经纪人、律师、专业会计师或其他 专业顾问。 本预案所述事项并不代表审批机关对于本次向特定对象发行股票相关事项 的实质性判断、确认或批准，本 ...

证券代码：002559 证券简称：亚威股份 江苏亚威机床股份有限公司 2025 年度向特定对象发行 A 股股票 方案的论证分析报告（修订稿） 二〇二六年一月 江苏亚威机床股份有限公司（以下简称"亚威股份"或"公司"）是在深圳 证券交易所主板上市的公司，为满足公司业务发展的资金需求，增强公司资本实 力，优化资本结构，根据《中华人民共和国公司法》《中华人民共和国证券法》 《上市公司证券发行注册管理办法》（以下简称"《发行注册管理办法》"）和 《江苏亚威机床股份有限公司章程》等有关法律、法规和规范性文件的规定，公 司拟向特定对象发行人民币普通股（A 股）并募集资金，公司编制了本次向特定 对象发行股票方案的论证分析报告。 本报告中如无特别说明，相关用语具有与《江苏亚威机床股份有限公司 2025 年度向特定对象发行 A 股股票预案》中相同的含义。 一、本次发行的背景和目的 （一）本次发行的背景 1、国家产业政策鼓励行业转型升级、创新发展 《国民经济和社会发展第十四个五年规划和 2035 年远景目标纲要》指出， 推动制造业优化升级，推动高端数控机床等产业创新发展是"十四五"时期的重 要任务。国家发改委发布的 2024 年 ...

股票简称：亚威股份 股票代码：002559.SZ 江苏亚威机床股份有限公司 （Jiangsu Yawei Machine Tool Co. , Ltd.） （江苏省扬州市江都区黄海南路仙城工业园） 2025 年度向特定对象发行股票 并在主板上市 募集说明书 （修订稿） 保荐机构（主承销商） 公告日期：二〇二六年一月 声 明 中国证监会、交易所对本次发行所作的任何决定或意见，均不表明其对申请 文件及所披露信息的真实性、准确性、完整性作出保证，也不表明其对发行人的 盈利能力、投资价值或者对投资者的收益作出实质性判断或保证。任何与之相反 的声明均属虚假不实陈述。 根据《证券法》的规定，证券依法发行后，发行人经营与收益的变化，由发 行人自行负责。投资者自主判断发行人的投资价值，自主作出投资决策，自行承 担证券依法发行后因发行人经营与收益变化或者证券价格变动引致的投资风险。 1-1-1 重大事项提示 本公司特别提请投资者注意，在作出投资决策之前，务必仔细阅读本募集说 明书正文内容，并特别关注以下重要事项。 一、本次向特定对象发行 A 股股票情况 1、本次向特定对象发行股票相关事项已经公司于 2025 年 1 月 20 ...